Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘22 |
|
|---|---|---|---|---|---|
| $1.98M | $3.74M | $1.77M | 80.3% |
|
|
| $1.96M | $7.33M | $5.38M | 66.8% |
|
|
| $1.93M | $2M | $71K | 89% |
|
|
279
Cytek Biosciences
CTKB
$566M
| $1.9M | $1.97M | $65K | 56.9% |
|
| $1.88M | $4.42M | $2.54M | 15.1% |
|
|
| $1.86M | $2.81M | $947K | 12.7% |
|
|
| $1.86M | $1.86M | $0 | 7.92% |
|
|
| $1.85M | $1.94M | $91K | 33.4% |
|
|
| $1.84M | $3.41M | $1.58M | 6.02% |
|
|
| $1.83M | $3.42M | $1.58M | 61.5% |
|
|
286
Xeris Biopharma Holdings
XERS
$1.04B
| $1.81M | $1.91M | $95K | 355% |
|
| $1.81M | $1.98M | $171K | 63.3% |
|
|
| $1.8M | $1.83M | $31K | 42.9% |
|
|
| $1.79M | $2.69M | $902K | 41.6% |
|
|
| $1.78M | $3.12M | $1.34M | 38.3% |
|
|
| $1.76M | $2.74M | $981K | 57.7% |
|
|
| $1.75M | $3.87M | $2.12M | 1.6% |
|
|
| $1.75M | $1.75M | $5K | 51.9% |
|
|
| $1.73M | $1.86M | $124K | 91.6% |
|
|
| $1.73M | $2.21M | $480K | 17.9% |
|
|
| $1.73M | $86.9M | $85.2M | 34.3% |
|
|
| $1.72M | $3.4M | $1.68M | 5.26% |
|
|
| $1.68M | $2.59M | $910K | 46.3% |
|
|
| $1.68M | $4.35M | $2.67M | 61.7% |
|
|
| $1.67M | $2.55M | $884K | 25.2% |
|